Study of the ZyMōt Sperm Selection Method & Its Effect on Embryo Ploidy.

Status Recruiting

Clinical Trial Summary

It has been described that 11% of men with semen values within the normal range established by the World Health Organization (WHO) have sperm DNA fragmentation. This has been associated with a lower fertilization rate, lower embryo development and, therefore, lower reproductive success. Focusing on the study of the integrity of the male genome can provide us information to diagnose infertility in the couple. The use of conventional sperm selection methods such as swim-up or density gradients has been a great advance in the improvement of male fertility. However, these methods use centrifugation in their protocol, a procedure that has been associated with sperm DNA damage. The ZyMōt is a chip based on microfluidic properties that allows the recovery of spermatozoa with lower DNA fragmentation rate without centrifugation of the semen sample. This new sperm selection method maintains all the advantages of conventional techniques, but decreasing DNA fragmentation associates to sperm recoveries techniques eventually improving reproductive rates. This quality would be beneficial for patients with unexplained infertility, recurrent pregnancy loss or clinical varicocele, factors that have been associated with a higher index of DNA fragmentation. However up to date there is evidence-based data supporting such improvement. The main objective of the present project is to evaluate the ZyMōt as a new non-invasive sperm selection device and to see its impact on the euploidy rate, comparing it with a sperm selection technique that is routinely used in the clinic: swim-up. At the same time, the effect that this new chip may have on sperm and other reproductive variables will be analyzed clinically, and molecularly with immunohistochemical and transcriptomic analyses in order to observe the impact of SDF(sperm DNA fragmentation) at the molecular and genomic level in oocytes with low reparative potential oocytes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06384794
Study type	Interventional
Source	Instituto Valenciano de Infertilidad, IVI VALENCIA
Contact	MARIA LUISA PARDIÑAS, Pre-Doc
Phone	+34 963.05.90.00
Email	marialuisa.pardiñas@ivirma.com
Status	Recruiting
Phase	N/A
Start date	June 29, 2023
Completion date	December 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04142112` - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation	N/A
Recruiting	`NCT04955782` - Abstinence Period and Semen Quality
Recruiting	`NCT05506722` - Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity	N/A
Not yet recruiting	`NCT03988361` - Selection of Non Apoptotic Human Sperm for in Vitro Fertilization by Using Magnetic Activated Cell Sorting (MACS)
Completed	`NCT03319654` - Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle	N/A
Not yet recruiting	`NCT05597631` - G-IVF and Sperm Parameters	N/A
Completed	`NCT05919186` - Effects of Antioxidant Supplementation of Culture Media on IVF Embryos	N/A
Recruiting	`NCT03588949` - Role of Nutritional Support in Idiopathic Male Infertility	N/A
Recruiting	`NCT03527043` - Impact of Escitalopram on Sperm DNA Fragmentation	Phase 2
Not yet recruiting	`NCT06050031` - Level of DNA-fragmentation Before and After Antioxidant-based Therapies in Male Infertility
Completed	`NCT02932865` - Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility
Completed	`NCT02310087` - Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures	N/A
Completed	`NCT00385346` - Expressive Writing in Male Infertility	N/A
Completed	`NCT04509583` - The Role of Micro Nutrient Supplement in Improvement of the Sperm DNA Fragmentation	N/A
Recruiting	`NCT04144244` - Comparison of the Effect of Microchip and Density Gradient Methods in Intrauterine Insemination Cycles	N/A
Recruiting	`NCT04452305` - Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting	N/A
Completed	`NCT05461079` - Sperm Phenotype and Differentially Methylated Regions
Recruiting	`NCT05205733` - Expanding Fertility Care to Poor and Low Resourced Settings Study	N/A
Completed	`NCT03960229` - The Evaluation of the Effect of Microfluidic Sperm Sorting Chip 'Labs-on-a-chip' on IVF Success in Male Factor	N/A
Not yet recruiting	`NCT03090438` - IVF Outcomes After Varicocele Repair	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy. — ZYMOT2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms